Katia Befort Selected Research

Katia Befort Research Topics

Disease

8	Substance-Related Disorders (Drug Abuse) 01/2021 - 06/2004
6	Pain (Aches) 01/2017 - 01/2002
4	Chronic Pain 01/2018 - 10/2011
3	Hypersensitivity (Allergy) 09/2005 - 01/2002
2	Bulimia (Binge Eating) 01/2021 - 01/2020
1	Body Weight (Weight, Body) 12/2021
1	Hyperphagia (Overeating) 12/2021
1	Obesity 12/2021
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2021
1	Neuroinflammatory Diseases 01/2020
1	Catalepsy 01/2017
1	Anxiety Disorders (Anxiety Disorder) 02/2015
1	Seizures (Absence Seizure) 02/2015
1	Mood Disorders (Mood Disorder) 02/2015
1	Heroin Dependence (Heroin Abuse) 10/2014
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2011
1	Brain Diseases (Brain Disorder) 10/2011
1	Mental Disorders (Mental Disorder) 04/2011
1	Neuralgia (Stump Neuralgia) 09/2005
1	Hyperalgesia 09/2004
1	Peripheral Nerve Injuries 10/2002
1	Inflammation (Inflammations) 01/2002

Drug/Important Bio-Agent (IBA)

5	Opioid Analgesics (Opioids)IBA 01/2018 - 09/2005
4	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020 - 06/2004
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
3	delta Opioid Receptors (delta Opioid Receptor)IBA 02/2015 - 10/2011
2	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 04/2011
2	Cocaine (Cocaine HCl)IBA 11/2021 - 01/2020
2	Heroin (Diamorphine)IBA 01/2017 - 10/2014
2	Opioid Receptors (Opioid Receptor)IBA 10/2014 - 01/2014
2	Serotonin (5 Hydroxytryptamine)IBA 10/2014 - 04/2011
1	SugarsIBA 12/2021
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2021
1	CB2 Cannabinoid ReceptorIBA 12/2021
1	EndocannabinoidsIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Sucrose (Saccharose)IBA 01/2021
1	SolutionsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2015
1	ConvulsantsIBA 02/2015
1	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2011
1	CannabinoidsIBA 04/2011
1	Glutamic Acid (Glutamate)FDA Link 04/2011
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 09/2005
1	Capsaicin (Zostrix)FDA Link 09/2004
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2004
1	D-Penicillamine (2,5)- EnkephalinIBA 04/2004
1	Ala(2)- deltorphin IIIBA 04/2004
1	OligonucleotidesIBA 10/2002
1	preproenkephalinIBA 01/2002
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2002
1	Freund's AdjuvantIBA 01/2002
1	Mitogen-Activated Protein KinasesIBA 01/2002
1	U 0126 (UO 126)IBA 01/2002

Therapy/Procedure

1	Injections 01/2018
1	Axotomy 09/2005
1	Ligation 09/2005
1	Spinal Injections 01/2002